Sugi Predict

Sugi Predict / Compounds / SCHEMBL705407

SCHEMBL705407

SCHEMBL705407

O=Cc1ccccc1P(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ CYP3A4 P08684 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TRIM24 O15164 1/20 0.41
▸ TRIM33 Q9UPN9 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ ERN1 O75460 4/20 0.39
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP2A6 P11509 1/20 0.37
▸ DRD1 P21728 2/20 0.37
▸ ESR1 P03372 2/20 0.37
▸ ESR2 Q92731 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28352956 0.96 TDP1 (0.50) TDP1LMNAKMT2AMEN1THRB
Ethylenediamine SCHEMBL29033280 0.91 TDP1 (0.41) TDP1LMNAKMT2AMEN1THRB
SCHEMBL31003883 0.91 LMNA (0.41) TDP1LMNAKMT2AMEN1THRB
Aniline SCHEMBL28503683 0.91 TDP1 (0.41) TDP1LMNAKMT2AMEN1THRB
SCHEMBL21734336 0.86 LMNA (0.60) TDP1LMNAKMT2AMEN1THRB
SCHEMBL31218232 0.86 LMNA (0.60) TDP1LMNAKMT2AMEN1THRB
SCHEMBL17898003 0.86 TDP1 (0.44) TDP1LMNAKMT2AMEN1THRB
SCHEMBL17513105 0.84 ALDH1A1 (0.45) TDP1LMNAKMT2AMEN1THRB
SCHEMBL12446803 0.84 TDP1 (0.43) TDP1LMNAKMT2AMEN1THRB
SCHEMBL29033277 0.82 TDP1 (0.34) TDP1LMNAKMT2AMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119593083-A Antistatic fabric and preparation method thereof 南通泰雅特服装有限公司 2025-03-11 — — CN claimed
WO-2024232536-A1 QUANTUM DOT, METHOD FOR MANUFACTURING QUANTUM DOT, PHOTOSENSITIVE RESIN COMPOSITION THEREOF, AND ELECTRONIC DEVICE 덕산네오룩스 주식회사 2024-11-14 — — WO claimed
CN-116139934-B Efficient catalyst for catalyzing hydroboration reaction of aldehyde and ketone and application 北京理工大学 2024-08-30 — — CN claimed
CN-117638097-A Preparation method and application of N, P co-doped Fe-based electrocatalyst 昆明理工大学 2024-03-01 — — CN claimed
CN-115025814-B Universal chiral catalyst and preparation method thereof 中国科学院成都有机化学有限公司 2024-02-09 — — CN claimed
CN-114014891-B Purine ring modified fluorescent probe and application thereof in detection of cobalt ions 江苏科技大学 2023-10-03 — — CN claimed
CN-114591365-B Luminous copper compound based on benzimidazole phosphine oxide ligand and preparation method and application thereof 郑州大学 2023-09-05 — — CN claimed
CN-113651856-B Phosphinimine zwitterionic complex and ligand, preparation method and application thereof 曲阜师范大学 2023-08-25 — — CN claimed
CN-116139934-A Efficient catalyst for catalyzing hydroboration reaction of aldehyde and ketone and application 北京理工大学 2023-05-23 — — CN claimed
CN-116063347-A Phosphine-1, 2-diphenyl ethylenediamine ligand with chiral benzene ring framework, and preparation method and application thereof 中国科学院大连化学物理研究所 2023-05-05 — — CN claimed
CN-101445518-A Preparation method of phosphine ligand and method for phosphine ligand to catalyze and synthetize biaryl and derivatives thereof SHANGHAI RECORD PHARMACEUTICAL (CN) 2009-06-03 — — CN claimed
CN-101121730-A Phosphaalkene ligand and its preparing method and use UNIV WUHAN (CN) 2008-02-13 — — CN claimed
EP-1299342-B1 METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2007-05-02 — — EP claimed
CN-1891707-A Oxime-phosphine compound, and its preparing method and use DALIAN CHEMICAL PHYSICS INST (CN) 2007-01-10 — — CN claimed
US-6809225-B2 BY HYDROCARBONYLATION/HYDROFORMYLATION WITH SUBSEQUENT REDUCTIVE AMINATION SCHWARZ PHARMA AG (DE) 2004-10-26 — — US claimed
US-6797745-B1 Hot melt inks containing styrene or terpene polymers XEROX CORPORATION 2004-09-28 — — US claimed
US-6780900-B1 ALDEHYDE COPOLYMER INK VEHICLE, A NONPOLYMERIC ALDEHYDE VISCOSITY MODIFIER, COLORANT, AN OPTIONAL CONDUCTIVITY ENHANCING AGENT, AN OPTIONAL ANTIOXIDANT, AND AN OPTIONAL UV ABSORBER XEROX CORPORATION 2004-08-24 — — US claimed
US-20040034080-A1 Method for producing 3,3-diarylpropylamines UCB PHARMA GMBH (DE) 2004-02-19 — — US claimed
EP-1299342-A1 METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES SCHWARZ PHARMA AG (DE) 2003-04-09 — — EP claimed
WO-2002004399-A1 METHOD FOR PRODUCING 3,3-DIARYLPROPYLAMINES SCHWARZ PHARMA AG (DE) 2002-01-17 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034080-A1 Method for producing 3,3-diarylpropylamines HNMT, CYP1A1, HRH3 TDP1 2037/4885LMNA 2386/4885KMT2A 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.